Terms: = Colorectal cancer AND BTG1, P62324, 694, ENSG00000133639 AND Treatment
36 results:
1. Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer.
Huang KC; Ke TW; Chen JY; Hong WZ; Chiang SF; Lai CY; Chen TW; Yang PC; Chen LC; Liang JA; Chen WT; Chao KSC
Sci Rep; 2023 Nov; 13(1):19440. PubMed ID: 37945630
[TBL] [Abstract] [Full Text] [Related]
2. Multi-Institutional Review From the Pediatric colorectal and Pelvic Learning Consortium of Minor Spinal Cord Dysraphism in the Setting of Anorectal Malformations: Diagnosis, treatment, and Outcomes.
Garvey EM; Fuller M; Frischer J; Calkins CM; Rentea RM; Ralls M; Wood R; Rollins MD; Avansino J; Reeder RW; Durham MM;
J Pediatr Surg; 2023 Aug; 58(8):1582-1587. PubMed ID: 37248140
[TBL] [Abstract] [Full Text] [Related]
3. Succinylation-associated lncRNA signature to predict the prognosis of colon cancer based on integrative bioinformatics analysis.
Zhang SM; Shen C; Gu J; Li J; Jiang X; Wu Z; Shen A
Sci Rep; 2023 May; 13(1):7366. PubMed ID: 37147453
[TBL] [Abstract] [Full Text] [Related]
4. Colon cancer Disparities in Stage at Presentation and Time to Surgery for Asian Americans, Native Hawaiians, and Pacific Islanders: A Study with Disaggregated Ethnic Groups.
Jain B; Bajaj SS; Patel TA; Vapiwala N; Lam MB; Mahal BA; Muralidhar V; Amen TB; Nguyen PL; Sanford NN; Dee EC
Ann Surg Oncol; 2023 Sep; 30(9):5495-5505. PubMed ID: 37017832
[TBL] [Abstract] [Full Text] [Related]
5. The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancy.
Zhang L; Zhao K; Kuang T; Wang K; Chai D; Qiu Z; Liu R; Deng W; Wang W
BMC Cancer; 2023 Jan; 23(1):101. PubMed ID: 36717809
[TBL] [Abstract] [Full Text] [Related]
6. Study on the Mechanism of Xiaotan Sanjie Recipe in the treatment of Colon cancer Based on Network Pharmacology.
Wang XW; Zhang CA; Ye M
Biomed Res Int; 2022; 2022():9498109. PubMed ID: 36033553
[TBL] [Abstract] [Full Text] [Related]
7. Risk factors for long-term survival in patients with ypN+ M0 rectal cancer after radical anterior resection.
Zeman M; Skałba W; Szymański P; Hadasik G; Żaworonkow D; Walczak DA; Czarniecka A
BMC Gastroenterol; 2022 Mar; 22(1):141. PubMed ID: 35346064
[TBL] [Abstract] [Full Text] [Related]
8. Deep learning for the prediction of early on-treatment response in metastatic colorectal cancer from serial medical imaging.
Lu L; Dercle L; Zhao B; Schwartz LH
Nat Commun; 2021 Nov; 12(1):6654. PubMed ID: 34789774
[TBL] [Abstract] [Full Text] [Related]
9. Extent of Surgical Resection in Inflammatory Bowel Disease Associated colorectal cancer: a Population-Based Study.
Bogach J; Pond G; Eskicioglu C; Simunovic M; Seow H
J Gastrointest Surg; 2021 Oct; 25(10):2610-2618. PubMed ID: 33559097
[TBL] [Abstract] [Full Text] [Related]
10. Ghost ileostomy versus conventional loop ileostomy in patients undergoing low anterior resection for rectal cancer (DRKS00013997): protocol for a randomised controlled trial.
Hüttner FJ; Probst P; Mihaljevic A; Contin P; Dörr-Harim C; Ulrich A; Schneider M; Büchler MW; Diener MK; Knebel P
BMJ Open; 2020 Oct; 10(10):e038930. PubMed ID: 33060088
[TBL] [Abstract] [Full Text] [Related]
11. Temporal improvements in loco-regional failure and survival in patients with anal cancer treated with chemo-radiotherapy: treatment cohort study (1990-2014).
Sekhar H; Malcomson L; Kochhar R; Sperrin M; Alam N; Chakrbarty B; Fulford PE; Wilson MS; O'Dwyer ST; Saunders MP; Renehan AG
Br J Cancer; 2020 Mar; 122(6):749-758. PubMed ID: 31932755
[TBL] [Abstract] [Full Text] [Related]
12. Patient-level factors associated with chronic opioid use in cancer: a population-based cohort study.
Cuthbert CA; Xu Y; Kong S; Boyne DJ; Hemmelgarn BR; Cheung WY
Support Care Cancer; 2020 Sep; 28(9):4201-4209. PubMed ID: 31900614
[TBL] [Abstract] [Full Text] [Related]
13. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
[No Abstract] [Full Text] [Related]
14. The value of biomarkers in colorectal cancer: Protocol for an overview and a secondary analysis of systematic reviews of diagnostic test accuracy.
Wang J; Liang W; Wang X; Min G; Chen W; Wang H; Yao N; Wang J;
Medicine (Baltimore); 2019 Jun; 98(24):e16034. PubMed ID: 31192959
[TBL] [Abstract] [Full Text] [Related]
15. Survival in Patients with High-Grade colorectal Neuroendocrine Carcinomas: The Role of Surgery and Chemotherapy.
Fields AC; Lu P; Vierra BM; Hu F; Irani J; Bleday R; Goldberg JE; Nash GM; Melnitchouk N
Ann Surg Oncol; 2019 Apr; 26(4):1127-1133. PubMed ID: 30706232
[TBL] [Abstract] [Full Text] [Related]
16. Impact of Time to Start Systemic Therapy on the Outcomes of Patients with Metastatic colorectal cancer Treated with First Line FOLFOX Chemotherapy; a Patient-Level Pooled Analysis of Two Clinical Trials.
Oweira H; Giryes A; Mannhart M; Decker M; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):1069-1074. PubMed ID: 30099922
[TBL] [Abstract] [Full Text] [Related]
17. Exploring the characteristics and potential disparities of non-migrant and migrant colorectal cancer patients regarding their satisfaction and subjective perception of care - a cross-sectional study.
Leonhardt M; Aschenbrenner K; Kreis ME; Lauscher JC
BMC Health Serv Res; 2018 Jun; 18(1):423. PubMed ID: 29879958
[TBL] [Abstract] [Full Text] [Related]
18. Down-regulation of B-Cell Translocation Gene 1 by Promoter Methylation in colorectal Carcinoma.
Jung YY; Sung JY; Kim JY; Kim HS
Anticancer Res; 2018 Feb; 38(2):691-697. PubMed ID: 29374692
[TBL] [Abstract] [Full Text] [Related]
19. Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy.
Delli Pizzi A; Cianci R; Genovesi D; Esposito G; Timpani M; Tavoletta A; Pulsone P; Basilico R; Gabrielli D; Rosa C; Caravatta L; Di Tommaso M; Caulo M; Filippone A
Abdom Radiol (NY); 2018 Sep; 43(9):2221-2230. PubMed ID: 29332248
[TBL] [Abstract] [Full Text] [Related]
20. Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers.
Bai Y; Qiao L; Xie N; Shi Y; Liu N; Wang J
PLoS One; 2017; 12(9):e0184902. PubMed ID: 28922388
[TBL] [Abstract] [Full Text] [Related]
[Next]
